Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-blind placebo-controlled trial

SARS-CoV-2 and its different variants caused a “wave and wave” pandemic pattern. During the first wave we demonstrated that standardized Brazilian green propolis extract (EPP-AF®) reduces length of hospital stay in adult patients with COVID-19. Afterwards, we decided to evaluate the impact of EPP-AF...

Descripción completa

Detalles Bibliográficos
Autores principales: Silveira, Marcelo Augusto Duarte, Menezes, Matheus de Alencar, de Souza, Sergio Pinto, Galvão, Erica Batista dos Santos, Berretta, Andresa Aparecida, Caldas, Juliana, Teixeira, Maurício Brito, Gomes, Marcel Miranda Dantas, Damiani, Lucas Petri, Bahiense, Bruno Andrade, Cabral, Julia Barros, De Oliveira, Cicero Wandson Luiz Macedo, Mascarenhas, Talita Rocha, Pinheiro, Priscila Carvalho Guedes, Alves, Milena Souza, de Melo, Rodrigo Morel Vieira, Leite, Flávia Mendes, Nonaka, Carolina Kymie Vasques, Souza, Bruno Solano de Freitas, Baptista, Nathália Ursoli, Teles, Flávio, da Guarda, Suzete Farias, Mendes, Ana Verena Almeida, Passos, Rogério da Hora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611696/
https://www.ncbi.nlm.nih.gov/pubmed/37891178
http://dx.doi.org/10.1038/s41598-023-43764-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611696/
https://www.ncbi.nlm.nih.gov/pubmed/37891178
http://dx.doi.org/10.1038/s41598-023-43764-w

Ejemplares similares